Role of a novel signal transduction pathway in GBS

一种新的信号转导途径在 GBS 中的作用

基本信息

  • 批准号:
    6805782
  • 负责人:
  • 金额:
    $ 30.53万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-09-30 至 2008-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The gram-positive pathogen Streptococcus agalactiae (group B streptococci, GBS) is the principal cause of human neonatal pneumonia, sepsis and meningitis. GBS is also an emerging pathogen of immunocompromised adults. We recently identified and characterized a novel eukaryotic-type serine/threonine protein kinase (Stk1) and its cognate phosphatase (Stp1) in GBS. Mutants of this signal transduction pathway exhibited pleiotropic effects on cell growth, virulence and segregation of GBS, indicating the importance of this pathway in the regulation of various cellular processes. In vitro phosphorylation studies revealed that these enzymes are essential for reversible phosphorylation of many GBS proteins. Using mass spectrometric analysis, we identified one of these targets as a anganese-dependent inorganic pyrophosphatase (PpaC). Pyrophophatases are critical for regulation of biosynthetic reactions in the cell. Based on our results, we hypothesize that this signal transduction pathway and post-translational modification of its targets are crucial for normal cellular functions in GBS. A combination of molecular, biochemical and proteomic approaches will be used to elucidate the role of this signal transduction pathway and its physiological substrates in growth and virulence of GBS. In aim 1, we will identify and characterize the upstream and downstream targets of this pathway. We will utilize modem proteomic techniques such as liquid chromatography and mass spectrometry to identify other key targets of this signal transduction pathway. We will perform deletion analysis and protein cross-linking studies, to identify proteins that bind to and activate Stk1. In Aim 2, we will complete functional characterization of the identified physiological substrate of this signal transduction pathway, PpaC. In Aim 3, we will construct mutations in ppaC and a few other regulated targets of this pathway, identified in aim 1, to assess their role in growth and survival of GBS. We anticipate that some of these genes including ppaC will be essential for GBS growth. As mutants inessential genes are not viable, we will use the modem RNA interference technology to evaluate their role in GBS growth and survival. Collectively, these studies will determine the biological significance of this signal transduction pathway and lead to the identification of novel targets of GBS, which may provide insights into their potential as antimicrobial targets.
描述(由申请方提供):革兰氏阳性病原体无乳链球菌(B族链球菌,GBS)是人类新生儿肺炎、败血症和脑膜炎的主要原因。GBS也是免疫功能低下的成人的新兴病原体。我们最近发现并鉴定了一种新的真核生物型丝氨酸/苏氨酸蛋白激酶(Stk 1)及其同源磷酸酶(Stp 1)在GBS。该信号转导途径的突变体对GBS的细胞生长、毒力和分离具有多效性,表明该信号转导途径在调节细胞的各种过程中具有重要作用。体外磷酸化研究表明,这些酶是许多GBS蛋白可逆磷酸化所必需的。使用质谱分析,我们确定了这些目标之一,作为一个anganese依赖性无机焦磷酸酶(PpaC)。焦磷酸酶对于调节细胞中的生物合成反应至关重要。基于我们的研究结果,我们推测,这一信号转导途径及其靶点的翻译后修饰对GBS的正常细胞功能至关重要。结合分子生物学和蛋白质组学的方法将被用来阐明这一信号转导途径及其生理底物在GBS的生长和毒力中的作用。在目标1中,我们将识别和表征该途径的上游和下游靶标。我们将利用现代蛋白质组学技术,如液相色谱法和质谱法,以确定这一信号转导途径的其他关键目标。我们将进行缺失分析和蛋白质交联研究,以确定结合并激活Stk 1的蛋白质。在目标2中,我们将完成该信号转导途径的已鉴定生理底物PpaC的功能表征。在目标3中,我们将构建ppaC和目标1中鉴定的该途径的一些其他调节靶点的突变,以评估它们在GBS生长和存活中的作用。我们预计其中一些基因(包括ppaC)对于GBS的生长至关重要。由于非必需基因的突变体不能存活,我们将使用现代RNA干扰技术来评估它们在GBS生长和存活中的作用。总的来说,这些研究将确定这种信号转导途径的生物学意义,并导致GBS的新靶点的鉴定,这可能会提供其作为抗菌靶点的潜力的见解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CRAIG E. RUBENS其他文献

CRAIG E. RUBENS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CRAIG E. RUBENS', 18)}}的其他基金

NEW MODEL OF ASCENDING INFECTION-RELATED PREMATURE BIRTH
感染相关早产上升的新模式
  • 批准号:
    8172769
  • 财政年份:
    2010
  • 资助金额:
    $ 30.53万
  • 项目类别:
NEW MODEL OF ASCENDING INFECTION-RELATED PREMATURE BIRTH
感染相关早产上升的新模式
  • 批准号:
    7958877
  • 财政年份:
    2009
  • 资助金额:
    $ 30.53万
  • 项目类别:
EXPERIMENTAL MODEL FOR CHORIOAMNIONITIS AND PRETERM LABOR
绒毛膜羊膜炎和早产的实验模型
  • 批准号:
    7716383
  • 财政年份:
    2008
  • 资助金额:
    $ 30.53万
  • 项目类别:
Role of a novel signal transduction pathway in GBS
一种新的信号转导途径在 GBS 中的作用
  • 批准号:
    6674398
  • 财政年份:
    2003
  • 资助金额:
    $ 30.53万
  • 项目类别:
Role of a novel signal transduction pathway in GBS
一种新的信号转导途径在 GBS 中的作用
  • 批准号:
    6845303
  • 财政年份:
    2003
  • 资助金额:
    $ 30.53万
  • 项目类别:
Role of a novel signal transduction pathway in GBS
一种新的信号转导途径在 GBS 中的作用
  • 批准号:
    7171915
  • 财政年份:
    2003
  • 资助金额:
    $ 30.53万
  • 项目类别:
Role of a novel signal transduction pathway in GBS
一种新的信号转导途径在 GBS 中的作用
  • 批准号:
    7008171
  • 财政年份:
    2003
  • 资助金额:
    $ 30.53万
  • 项目类别:
Early host microbial interactions in S. aureus pneumonia
金黄色葡萄球菌肺炎的早期宿主微生物相互作用
  • 批准号:
    6820113
  • 财政年份:
    2003
  • 资助金额:
    $ 30.53万
  • 项目类别:
Role of penicillin binding protein 1a in GBS virulence
青霉素结合蛋白 1a 在 GBS 毒力中的作用
  • 批准号:
    6611349
  • 财政年份:
    2002
  • 资助金额:
    $ 30.53万
  • 项目类别:
Role of penicillin binding protein 1a in GBS virulence
青霉素结合蛋白 1a 在 GBS 毒力中的作用
  • 批准号:
    6521686
  • 财政年份:
    2002
  • 资助金额:
    $ 30.53万
  • 项目类别:

相似海外基金

Bridging the Gap: Next-Gen Tools for Accurate Prediction of Disordered Protein Binding Sites
弥合差距:准确预测无序蛋白质结合位点的下一代工具
  • 批准号:
    24K15172
  • 财政年份:
    2024
  • 资助金额:
    $ 30.53万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Design of protein crystal templates with multiple binding sites for tracking metal complex reactions.
设计具有多个结合位点的蛋白质晶体模板,用于跟踪金属络合物反应。
  • 批准号:
    23K04928
  • 财政年份:
    2023
  • 资助金额:
    $ 30.53万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Dynamic changes in PIP2 binding sites and their impact on axonal targeting and function of epilepsy-associated KCNQ/Kv7 channels
PIP2 结合位点的动态变化及其对癫痫相关 KCNQ/Kv7 通道的轴突靶向和功能的影响
  • 批准号:
    10744934
  • 财政年份:
    2023
  • 资助金额:
    $ 30.53万
  • 项目类别:
Computational methods to identify small molecule RNA binding sites
识别小分子 RNA 结合位点的计算方法
  • 批准号:
    573688-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 30.53万
  • 项目类别:
    University Undergraduate Student Research Awards
Identification of potential drug binding sites within allosteric networks in cyclic nucleotide modulated channels
环核苷酸调节通道变构网络内潜在药物结合位点的鉴定
  • 批准号:
    10704557
  • 财政年份:
    2022
  • 资助金额:
    $ 30.53万
  • 项目类别:
Identification of potential drug binding sites within allosteric networks in cyclic nucleotide modulated channels
环核苷酸调节通道变构网络内潜在药物结合位点的鉴定
  • 批准号:
    10537846
  • 财政年份:
    2022
  • 资助金额:
    $ 30.53万
  • 项目类别:
Identifying new types of inhibitors in quinone binding sites in photosynthetic enzymes
鉴定光合酶醌结合位点的新型抑制剂
  • 批准号:
    2753921
  • 财政年份:
    2022
  • 资助金额:
    $ 30.53万
  • 项目类别:
    Studentship
Development of broad nanovaccines targeting diverse coronavirus receptor-binding sites
开发针对不同冠状病毒受体结合位点的广泛纳米疫苗
  • 批准号:
    10328140
  • 财政年份:
    2022
  • 资助金额:
    $ 30.53万
  • 项目类别:
Exploiting Water Network Perturbations in Protein Binding Sites
利用蛋白质结合位点的水网络扰动
  • 批准号:
    10621368
  • 财政年份:
    2021
  • 资助金额:
    $ 30.53万
  • 项目类别:
SBIR Phase I: Nonlinear optical method for identifying protein-ligand binding sites
SBIR 第一阶段:识别蛋白质-配体结合位点的非线性光学方法
  • 批准号:
    2111821
  • 财政年份:
    2021
  • 资助金额:
    $ 30.53万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了